XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Earnings (Loss) per Share | 3 Months Ended
--- | ---
May 04, 2024
Earnings Per Share [Abstract] |
Earnings (Loss) per Share | Earnings (Loss) per Share The computation of basic and diluted net earnings (loss) per common share attributable to common stockholders is (in thousands, except per share data):
| Three Months Ended |  |
| May 4, 2024 |  | Apr 29, 2023 |  |  |  |
Net earnings (loss) attributable to Guess?, Inc. | $ | 13,022 |  |  | $ | (11,805) |  |  |  |  |
Less net earnings attributable to nonvested restricted stockholders | 318 |  |  | 164 |  |  |  |  |
Net earnings (loss) attributable to common stockholders | 12,704 |  |  | (11,969) |  |  |  |  |
Add interest expense related to the convertible senior notes 1 | 122 |  |  | — |  |  |  |  |
Net earnings (loss) attributable to common stockholders used in diluted computations | $ | 12,826 |  |  | $ | (11,969) |  |  |  |  |
Weighted average common shares used in basic computations | 52,908 |  |  | 54,348 |  |  |  |  |
Effect of dilutive securities: |  |  |  |  |  |  |
Stock options and restricted stock units 2 | 1,538 |  |  | — |  |  |  |  |
Convertible senior notes 1 | 1,092 |  |  | — |  |  |  |  |
Weighted average common shares used in diluted computations | 55,538 |  |  | 54,348 |  |  |  |  |
Net earnings (loss) per common share attributable to common stockholders:
Basic | $ | 0.24 |  |  | $ | (0.22) |  |  |  |  |
Diluted | $ | 0.23 |  |  | $ | (0.22) |  |  |  |  |
______________________________________________________________________ Notes: 1 During the three months ended April 29, 2023, there were 12,834,308 potentially dilutive shares related to the convertible senior notes that were not included in the computation of diluted weighted average common shares and common equivalent shares outstanding because their effect would have been antidilutive given the Company’s net loss. 2 During the three months ended April 29, 2023, there were 1,351,331 potentially dilutive shares related to stock options and restricted stock units that were not included in the computation of diluted weighted average common shares and common equivalent shares outstanding because their effect would have been antidilutive given the Company’s net loss. During the three months ended May 4, 2024 and April 29, 2023, equity awards granted for 149,626 and 1,091,454 shares, respectively, of the Company’s common stock were outstanding but were excluded from the computation of diluted weighted average common shares and common equivalent shares outstanding because the assumed proceeds resulted in these awards being antidilutive. During the three months ended May 4, 2024, 14,741,039 potentially dilutive shares related to the convertible senior notes were excluded from the computation of diluted weighted average common shares and common equivalent shares outstanding because their inclusion would have been antidilutive. For each of the three months ended May 4, 2024 and April 29, 2023, the Company excluded 300,000 nonvested stock units which were subject to the achievement of market-based vesting conditions from the computation of diluted weighted average common shares and common equivalent shares outstanding because these conditions were not achieved as of May 4, 2024 and April 29, 2023, respectively. Warrants related to the 2.00% convertible senior notes due April 2024 (the “2024 Notes”) to purchase approximately 1.3 million and 4.6 million shares of the Company’s common shares at adjusted strike prices of $41.45 and $45.31 per share were outstanding as of May 4, 2024 and April 29, 2023, respectively. Warrants related to the 3.75% convertible senior notes due April 2028 (the “2028 Notes”, and together with the 2024 Notes, the “Notes”) to purchase approximately 15.7 million shares of the Company’s common shares at an adjusted strike price of $37.89 per share were outstanding as of May 4, 2024. Warrants related to the 2028 Notes to purchase approximately 11.1 million shares of the Company’s common shares at an initial strike price of $41.80 per share were outstanding as of April 29, 2023. During the three months ended May 4, 2024, these warrants were excluded from the computation of diluted net earnings per share since the warrants’ adjusted strike price was greater than the average market price of the Company’s common stock. During the three months ended April 29, 2023, these warrants were excluded from the computation of diluted net earnings per share because their effect would have been antidilutive given the Company’s net loss. See Note 11 for more information regarding the Notes.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration